(thirdQuint)Study of Decision Making in Patients Participating in Phase I Clinical Trials.

 OBJECTIVES: - Determine the range of personality traits of patients enrolled in a phase I clinical trial.

 - Determine these patients' understanding of their medical situation and prognosis.

 - Determine these patients' understanding of risks and benefits of phase I clinical trials.

 - Determine these patients' reasons for participating in a phase I clinical trial.

 - Determine the risk/benefit trade-offs of these patients.

 - Determine the existential outlook of these patients.

 - Determine the information gathering nature of these patients.

 OUTLINE: This is a multicenter study.

 Before beginning phase I clinical trial treatment, patients complete a survey over 30-45 minutes administered by an interviewer.

 Patients then self-administer the Temperament and Character Inventory assessment over 30 minutes.

 PROJECTED ACCRUAL: Approximately 250 patients will be accrued for this study within 6 months.

.

 Study of Decision Making in Patients Participating in Phase I Clinical Trials@highlight

RATIONALE: Studying individuals who are enrolled in phase I clinical trials may help to improve the way in which clinical trials are conducted.

 PURPOSE: This clinical trial is studying patients' personality traits, reasons for participating in the trial, and understanding of their medical situation, prognosis, and risks and benefits of participating in a phase I trial.

